Définition de la notion de consolidation applicable à la situation des maladies évolutives

La notion de consolidation est centrale en droit de la responsabilité, car elle marque le point de départ du délai de prescription de l’action en responsabilité.

La consolidation correspond à la fin de la maladie traumatique, c’est-à-dire à la date, fixée par l’expert médical, de stabilisation des conséquences des lésions organiques et physiologiques. Cette date marque la frontière entre les préjudices à caractère temporaire et ceux à caractère définitif.

La consolidation est un terme technique qui signifie qu’à un moment donné, le médecin qui suit l’état de santé de l’assuré considère que sa maladie ou que ses blessures sont devenues définitives. Autrement dit, la guérison complète est impossible selon le médecin. Les blessures sont stabilisées et n’évoluent plus.

Il convient de ne pas confondre “consolidation” et “rechute“, la seconde étant une aggravation brutale de l’état de santé de la victime dont la constatation médicale intervient après la “guérison” ou la “consolidation“.

En savoir plus

• • Choix de la victime de cesser tout traitement et date de consolidation du dommage, dalloz-actualite, 17 janv. 2018.
  • Conseils Juridiques aux Victimes du Distilbène DES.
  • Procès Distilbène DES: les éléments requis pour un dossier solide.
  • L’expérience judiciaire individuelle et collective des victimes du Distilbène.
  • DES Cases, Lawsuits, Litigation.

DES Lawsuits Informational Brochure

New long term effects discovered, affecting children of mothers who had used DES, now filing lawsuits.

Rottenstein Law Group LLP

• DES Breast Cancer Injury Lawsuit.
• Free DES Lawsuits Informational Brochure.
• Rottenstein Contact – Twitter.

Brochure by Rottenstein Law Group LLP

About DES Lawsuits

Law Papers and Theories (in Reference to DES Cases)

• 2016 The Dutch Act on Collective Settlement of Mass Claims (WCAM) Goes Global Again: A Forum Outside the United States to Resolve Mass Claims Disputes Internationally.
• 2014 DES daughters in France: experts’ points of viewon the various genital, uterine and obstetric pathologies, and in utero DES exposure.
• 2013 Synthetic Hormone Use in Beef and The Us Regulatory Dilemma.
• 2012 Market Share Liability – Did New York Go Too Far?
• 2011 Boston Federal Courthouse holds the first DES Breast Cancer court cases on behalf of 53 DES Daughters.
• 2011 Distilbène®: 20 Years of Legal Battle – DES French lawsuits 1991-2011, DES French court cases history.
• 2011 Pharmaceutical Product Liability.
• 2011 Transgenerational Tort Liability for Epigenetic Disease.
• 2008 Alternative Liability and Deprivation of Remedy: Teaching Old Tort Law New Tricks.
• 2008 The Bitterest Pill.
• 2008 The Dutch Class Action (Financial Settlement) Act (WCAM).
• 2007 Against Genetic Exceptionalism: An Argument in Favor of the Viability ofPreconception Genetic Torts.
• 2007 Compensation for Diethylstilbestrol Injury, an opinion.
• 2007 Defendant Indeterminacy: New Wine into Old Skins.
• 2007 (Collective) Settlement effected for damages for victims of diethylstilbestrol (DES).
• 2005 The Challenge to the Individual Causation Requirement in Mass Products Torts.
• 2002 Hormones as growth promoters: the precautionary principle or a political risk assessment?
• 2002 The DES story: long-term consequences of prenatal exposure – Late lessons from early warnings: the precautionary principle 1896–2000.
• 2001 Consequences of diethylstilbestrol during pregnancy; 50 years later still a significant problem – How long should medical records be kept for the DES-exposed?
• 2001 Preconception Tort Law in an Era of Assisted Reproduction: Applying a Nexus Test for Duty.
• 2000 An Examination of the Legal and Ethical Public Policy Consideration Underlying DES Market Share Liability.
• 1999 Book: Causation and Risk in the Law of Torts – Scientific Evidence and Medicinal Product Liability.
• 1999 Concert of action by substantial assistance : what ever happened tounconscious aiding and abetting?
• 1999 Expert witness testimony: a trial judge’s perspective.
• 1998 HIV, Women and Access to Clinical Trials: Tort Liability and Lessons from DES.
• 1996 Judicially Compelled Disclosure of Researcher’s Data: A Judge’s View.
• 1996 Researchers’ Reactions to Compelled Disclosure of Scientific Information.
• 1994 Book: Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies (with DES Case Study – DES administration without consent).
• 1994 The Birth of Preconception Torts in Missouri.
• 1993 Adapting Due Process to Match Your Tort: In re DES: A Novel Approach to Jurisdiction.
• 1993 Suspended Judgment – The 1953 Clinical Trial of Diethylstilbestrol During Pregnancy: Could It Have Stopped DES Use?
• 1991 Market Share Liability in DES Cases: The Unwarranted Erosion of Causation in Fact.
• 1991 Medicine and the Law; Diethylstilboestrol third-generation injury claims.
• 1991 Preconception tort liability: recognizing a strict liability cause of action for DES grandchildren.
• 1991 Preconception Tort Liability – The Duty to Third Generations – Enright v. Eli Lilly & Co.
• 1991 The Causation Requirement: Guardian of Fairness or Obstacle to Justice – Making Sense of a Decade of DES Litigation.
• 1991 The Indeterminate Defendant in Products Liability Litigation and a Suggested Approach for Ohio.
• 1990 Appellate Division Recognizes Preconception Tort Liability in Favor of DES Granddaughter.
• 1990 Diethylstilbestrol, teratogenesis, and carcinogenesis: medical/legal implications of its long-term sequelae, including third generation effects.
• 1990 From Res Ipsa Loquitur to Diethylstilbestrol: The Unidentifiable Tortfeasor in California.
• 1990 Market Share Liability New York Style: Negligence in the Air.
• 1990 Risk Exposure as Injury: Alleviating the Injustice of Tort Causation Rules.
• 1988 The Paradox of Statutes of Limitations in Toxic Substances Litigation.
• 1986 Intra-Industry Joint Liability: Implications for Marketing.
• 1986 The DES Manufacturer Identification Problem: A Florida Public Policy Approach.
• 1985 Clinical findings and legal resolution in sexual assault.
• 1985 Failure to Identify the Defendant in Tort Law: Towards a Legislative Solution.
• 1984 Fear of Disease and Delayed Manifestation of Injuries: A Solution or a Pandora’s Box?
• 1984 The diethylstilbestrol dilemma. Who should pay?
• 1983 DES and the Identification Problem.
• 1983 Book: DES: The Bitter Pill.
• 1983 Generic Product Risks: The Case Against Comment k and for Strict Tort Liability.
• 1983 Identifying and Tracing a Population at Risk : The DESAD ProjectExperience
• 1983 Proving Causation in Toxic Torts Litigation.
• 1983 Theories of recovery for DES damage: is tort liability the answer?
• 1982 Bichler v. Lilly: Applying Concerted Action to the DES Cases.
• 1982 DES and Emotional Distress: Payton v. Abbott Labs.
• 1982 Book: Multiple Causation in Tort Law: Reflections on the DES Cases.
• 1982 Overcoming the indentification burden in DES litigation: the Market Share Liability theory.
• 1982 Product Liability of the 1980s: Repose Is Not the Destiny of Manufacturers.
• 1982 Toxic Substances Litigation: DES Cases and Identification of Parties.
• 1981 California Expands Tort Liability under the Novel Market Share Theory: Sindell v. Abbott Laboratories.
• 1981 Compensation for Drug Injury, Product liability all dressed up American style.
• 1981 Book: Daughters at risk: A personal DES history.
• 1981 Book: DES Daughter: The Joyce Bichler story.
• 1981 Book: DES: The Complete Story.
• 1981 Emerging Theories of Proof in Products Liability: Resolving the Problem of Identifying DES Manufacturers.
• 1981 Lilly, DES and the law.
• 1981 Market Share Liability: A New Method of Recovery for D.E.S. Litigants.
• 1981 Book: Market Share Liability: an Answer to the DES Causation Problem.
• 1981 Market Share Liability adopted to Overcome Defendant Identification Requirement in DES Litigation, Sindell v. Abbott Laboratories.
• 1981 Market Share Liability for DES (Diethylstilbestrol) Injury: A New High Water Mark in Tort Law: Sindell v. Abbott Laboratories.
• 1981 Sindell v. Abbott Labs: a Market Share Approach to DES Causation.
• 1981 Statutes of limitations: the special problem of DES suits.
• 1981 The Relevancy of Drug Efficacy Evidence in Strict Liability Actions: Needham v. White Laboratories, Inc.
• 1980 Liability in Mass Immunization Programs.
• 1980 Limitation of Collateral Estoppel in Products Liability Litigation, Katz v. Eli Lilly & Co.
• 1980 Manufacturers’ Liability Based on a Market Share Theory: Sindell v. Abbott Laboratories.
• 1980 Payton v. Abbott Laboratories: an analysis of the Massachusetts DES class action suit.
• 1980 The Liability of Pharmaceutical Manufacturers for Unforeseen Adverse Drug Reactions.
• 1978 DES and a Proposed Theory of Enterprise Liability.
• 1978 Products-Liability Class Suits for Injunctive Relief Under Federal Rule 23.

Famous DES Cases

• 2013 DES Breast Cancer Trial – Settlement reached for the Melnick sisters.
• 2013 DES Breast Cancer Trial – Jury Selected.
• 2013 DES Breast Cancer Trial – Jackie White Interview.
• 2013 DES Breast Cancer Trial – MacCormack Interview.
• 2013 DES Breast Cancer Trial – McCarthy Interviews.
• 2012 Mazzei v. Abbott Laboratories & Co.
• 2007 Galvin v. Eli Lilly & Co.
• 2007 Kelley v. Eli Lilly & Co.
• 2006 Clayton v. Eli Lilly & Co.
• 2005 Baughn v. Eli Lilly & Co.
• 2005 Bortell v. Eli Lilly & Co.
• 2005 Dunseth v. Eli Lilly & Co.
• 2005 Gassmann v. Eli Lilly & Co.
• 2005 Reeves v. Eli Lilly & Co.
• 2004 Albers v. Eli Lilly & Co. (2).
• 2003 Albers v. Eli Lilly & Co. (1).
• 2002 Armata v. Abbott Labs. (2).
• 2001 Armata v. Abbott Laboratories. (1).
• 1998 Sutowski v. Eli Lilly & Co.
• 1997 Kurczi v. Eli Lilly & Co.
• 1997 Matter of New York County DES Actions.
• 1997 Wetherill v. Eli Lilly & Co. (2).
• 1997 Wood v. Eli Lilly & Co. (3).
• 1997 Wood v. Eli Lilly & Co. (2).
• 1997 Wood v. Eli Lilly & Co. (1).
• 1996 Mevis v. Eli Lilly & Co.
• 1996 Wetherill v. Eli Lilly & Co. (1).
• 1995 Braune v. Abbott Laboratories.
• 1995 Fraser v. Eli Lilly & Co.
• 1995 Jellow v. Abbott Laboratories.
• 1994 Matter of New York County DES Litigation.
• 1994 Millar-Mintz v. Abbott Laboratories.
• 1994 Wind v. Eli Lilly & Co. (2).
• 1994 Wood v. Eli Lilly & Co.
• 1993 Ashley v. Boehringer Ingelheim Pharmaceuticals.
• 1993 Bilello v. Abbott Laboratories.
• 1993 Burgess v. Eli Lilly & Co. (2).
• 1993 Burgess v. Eli Lilly & Co. (1).
• 1993 Moll v. Abbott Laboratories. (2).
• 1993 Hartnett v. Schering Corp.
• 1993 Wind v. Eli Lilly & Co. (1).
• 1992 Bowe v. Abbott Laboratories, Inc.
• 1992 Grover v. Eli Lilly & Co.
• 1992 Hibbs v. Abbott Laboratories.
• 1992 In Re DES Cases (1971 to 1991).
• 1992 Matter of DES Market Share Litigation, State of New York.
• 1992 Moll v. Abbott Lab. (1).
• 1992 Silveri v. Eli Lilly & Co.
• 1991 Anderson v. Eli Lilly & Co. (2).
• 1991 Conley v. Boyle Drug Co. (2).
• 1991 Enright v. Eli Lilly & Co. (3).
• 1991 Matter of New York County DES Litigation.
• 1990 Allen v. Abbott Labs.
• 1990 Anderson v. Eli Lilly & Co. (1).
• 1990 Bowen v. Eli Lilly & Co.
• 1990 Castrignano v. E.R. Squibb & Sons, Inc. (2).
• 1990 Clark v. Abbott Labs. (2).
• 1990 Enright v. Eli Lilly & Co. (2).
• 1990 Korren v. Eli Lilly & Co.
• 1990 Krist v. Eli Lilly & Co.
• 1990 Metauro v. Abbott Labs.
• 1990 Shields v. Eli Lilly & Co. (3).
• 1990 Smith v. Eli Lilly & Co. (2).
• 1990 Singer v. Eli Lilly & Co.
• 1990 Sorrells v. Eli Lilly & Company.
• 1989 Besser v. Squibb & Sons.
• 1989 Clark v. Eli Lilly & Co.
• 1989 Hymowitz v. Eli Lilly & Co.
• 1989 Murphy v. Eli Lilly & Co.
• 1989 Phillips v. Cooper Laboratories.
• 1989 Wood v. Eli Lilly & Co.
• 1988 Brown v. Eli Lilly & Co. memorendum.
• 1988 Brown v. Superior Court.
• 1988 Castrignano v. E.R. Squibb & Sons. (1).
• 1988 Enright v. Eli Lilly & Co. (1).
• 1988 Johnson v. Eli Lilly & Co.
• 1988 Jolly v. Eli Lilly & Co.
• 1988 Kortenhaus v. Eli Lilly & Co.
• 1988 Maloney v. American Pharmaceutical Co.
• 1988 Needham v. White Laboratories, Inc. (2).
• 1988 Shields v. Eli Lilly & Co. (2).
• 1988 Shields v. Eli Lilly & Co. (1).
• 1988 Shirkey v. Eli Lilly & Co.
• 1988 Smith v. Eli Lilly & Co. (1).
• 1988 Tidler v. Eli Lilly & Co.
• 1988 Tigue v. E.R. Squibb & Sons, Inc.
• 1987 George v. Parke-Davis.
• 1987 Greene v. Abbott Labs.
• 1987 Rubel v. Eli Lilly & Co.
• 1987 Tigue v. Squibb & Sons.
• 1986 Burnside v. Abbott Laboratories.
• 1986 Hadden v. Eli Lilly & Co.
• 1986 Mulcahy v. Eli Lilly & Co.
• 1985 Anthony v. Abbott Laboratories.
• 1985 Bogorad v. Eli Lilly & Co.
• 1985 Cavanaugh v. Abbott Laboratories.
• 1985 Conley v. Boyle Drug Co. (1).
• 1985 Eli Lilly & Co. v. Home Ins Co. (2).
• 1985 Errichiello v. Eli Lilly & Co.
• 1985 Kaufman  v. Eli Lilly & Co. (2).
• 1985 Kensinger v. Abbott Laboratories.
• 1985 Magallanes v. Superior Court.
• 1985 McCormack v. Abbott Laboratories.
• 1985 McMahon v. Eli Lilly & Co.
• 1985 Murphy v. E.R. Squibb & Sons, Inc.
• 1985 Pine v. Eli Lilly & Co.
• 1985 Schaeffer v. Eli Lilly & Co.
• 1984 Abel v. Eli Lilly & Co. (2).
• 1984 Collins v. Eli Lilly & Co.
• 1984 Eli Lilly & Co. v. Home Ins. Co. (1).
• 1984 Fleishman v. Eli Lilly & Co. (2).
• 1984 Glater v. Eli Lilly & Co. (2).
• 1984 Kaufman v. Eli Lilly & Co. (1).
• 1984 Lord v. Parke, Davis & Company.
• 1984 Martin v. Abbott Laboratories.
• 1984 Zafft v. Eli Lilly & Co.
• 1983 Fleishman v. Eli Lilly & Co. (1).
• 1983 Glater v. Eli Lilly & Co. (1).
• 1983 Mathis v. Eli Lilly & Co.
• 1983 McElhaney v. Eli Lilly & Co. (2) memorendum.
• 1983 McElhaney v. Eli Lilly & Co. (1).
• 1983 Plummer v. Abbott Laboratories.
• 1983 Trahan v. E.R. Squibb & Sons, Inc.
• 1983 Wetherill v. University of Chicago : DES administration without consent.
• 1983 Yustick v. Eli Lilly & Co.
• 1982 Bichler v. Eli Lilly & Co. (2).
• 1982 Dawson v. Eli Lilly & Co.
• 1982 Helmrich v. Eli Lilly & Co.
• 1982 Miles Laboratories, Inc. v. Superior Court.
• 1982 Morton v. Abbott Laboratories.
• 1982 O’Brien v. Eli Lilly & Co.
• 1982 Payton v. Abbott Labs. (2) memorendum.
• 1982 Pipon v. Burroughs-Wellcome Co.
• 1982 Renfroe v. Eli Lilly & Co.
• 1981 Bichler v. Eli Lilly & Co. (1).
• 1981 Diamond v. E.R. Squibb & Sons, Inc. (2).
• 1981 Mizell v. Eli Lilly & Co.
• 1981 Namm v. Charles E. Frosst & Co.
• 1981 Needham v. White Laboratories, Inc. (1).
• 1981 Payton v. Abbott Labs. (1).
• 1981 Ryan v. Eli Lilly & Co.
• 1981 Tate v. Eli Lilly & Co.
• 1980 Ferrigno v. Eli Lilly & Co.
• 1980 Sindell v. Abbott Laboratories.
• 1979 Abel v. Eli Lilly & Company. (1).
• 1979 Diamond v. E.R. Squibb & Sons, Inc. (1).
• 1979 Lyons v. Premo Pharmaceutical Labs, Inc.
• 1979 Morrissy v. Eli Lilly & Co.
• 1978 Gray v. United States.
• 1978 McCreery v. Eli Lilly & Co.
• 1978 Mink v. University of Chicago : DES administration without consent.
• 1977 Bichler v. Willing : first DES case.

Never heard of DES Cancer? You will… – Diethylstilbestrol Legal News

To be known as a “DES Daughter” is not quite the same as proud membership in a revered woman’s group akin to the suffragette movement that promoted women’s rights and feminism in Great Britain and elsewhere in the early 1900’s.

Read Never Heard of DES Cancer? You Will…

More DES posts via lawyersandsettlements.com